ICB/PSA6/ART&OI/GFNFMII/21/19
October 14, 2019
Tender Code: ICB/PSA6/ART&OI/GFNFMII/21/19
Award Status: Full Winners List
Award Date: 10/14/2019
Tender Award: Download
Unsuccessful Bidders:
Technical Evaluation Result:
ETHIOPIAN PHARMACEUTICALS SUPPLY AGENCY(EPSA). | |||||||||||
Official winner list of Tender NO ICB/PSA6/ART&OI/GFNFMII/21/19 | |||||||||||
Item.No. | Description | Unit | Quantity | Winner | Currency | ||||||
Supplier | Country | Unit price (FOB) | Payment Term | Delivery Time | Manufacturer | Remark | |||||
1 | Lamivudine (3TC) + Dolutegravir (DTG) + Tenofovir (TDF) – (300mg + 50mg + 300mg) – Tablet | 90 | 870,295 | Mylan laboratories Ltd | India | USD | 15.89 | CAD | Within 90 days | Mylan laboratories. | |
2 | Lopinavir + Ritonavir – (40mg + 10mg) Capsule | 30 | 40,984 | Cipla Limited | India | USD | 19.20 | CAD | 60-90 DAYS | Cipla Limited | |
3 | Raltegravir (RAL) – 100mg – Tablet | 60 | 2,878 | retender | …… | ……. | |||||
4 | Lopinavir + Ritonavir – (200mg + 50mg) Tablet | 120 | 33,213 | Mylan Laboratories Limited | India | USD | 18.40 | CAD | Within 90 days | Mylan laboratories. | |
5 | Sulphamethozazole + Trimetohprim (200mg+40mg)/5ml mixtur | 100ml | 419946 | Leben Laboratories Pvt.Ltd | India | USD | 0.255 | CAD | 90 days | Leben Laboratories Pvt.Ltd | |
6 | Sulphamethoxazole + Trimethoprim (400mg+80mg) – Tablet | 10*100 | 3,489 | Leben Laboratories Pvt.Ltd | India | USD | 8.990 | CAD | 90 days | Leben Laboratories Pvt.Ltd | |
7 | Sulphamethoxazole + Trimethoprim (800mg+160mg) – Tablet | 10*100 | 66190 | CANCELLED | ….. | …. | …… | ….. | ….. | …… |
Reason of unsuccessfulness for tender No ICB/PSA6/ART&OI/GFNFMII/21/19 is illustrated as below. | |||||
item number | Prdoduct Description | Name of competitor suppliers | Status | reason of unsuccessfulness(if it is unsuccessful) | remark |
1 | Lamivudine (3TC) + Dolutegravir (DTG) + Tenofovir (TDF) – (300mg + 50mg + 300mg) – Tablet | Aurobindo pharma ltd | unsuccessful | Price incompetence | |
Emacure Pharmaceuticals | unsuccessful | Listed as EPR | |||
Cipla Ltd | unsuccessful | Price incompetence | |||
Hetero Labs Limited | unsuccessful | Price incompetence | |||
Human well | unsuccessful | Not Listed in the GFQAP for this specific product | |||
Laurus | unsuccessful | Price incompetence | |||
Macleods Pharmaceuticals | unsuccessful | Not Listed in the GFQAP for this specific product | |||
Mylan laboratories Lited | winner | …………………. | |||
2 | Lopinavir + Ritonavir – (40mg + 10mg) Capsule | Cipla Ltd | winner | ………………. | |
Human well | unsuccessful | Technical and Delivery,Previous performance | |||
Mylan laboratories Lited | unsuccessful | Price incompetence | |||
3 | Raltegravir (RAL) – 100mg – Tablet | ………… | RETENDERED | …………….. | |
4 | Lopinavir + Ritonavir – (200mg + 50mg) Tablet | Cipla Ltd | unsuccessful | Price incompetence | |
Hetero Labs Limited | unsuccessful | Price incompetence | |||
Macleods Pharmaceuticals | unsuccessful | Price incompetence | |||
Mylan laboratories Lited | winner | ……………………………….. | |||
5 | Sulphamethozazole + Trimetohprim (200mg+40mg)/5ml mixtur | EPICO | unsuccessful | No Valid FMHACA Cert. | |
Human well | unsuccessful | Technical and Delivery,Previous performance | |||
Leben | winner | …………. | |||
Macleods Pharmaceuticals | unsuccessful | Price incompetence | |||
Millan Laboratories Ltd | unsuccessful | No Valid FMHACA Cert. | |||
Mission Pharma | unsuccessful | No Valid FMHACA Cert. | |||
Universal Coperation | unsuccessful | No Valid FMHACA Cert. | |||
6 | Sulphamethoxazole + Trimethoprim (400mg+80mg) – Tablet | Human Well | unsuccessful | Technical and Delivery,Previous performancee | |
Leben | winner | ………………….. | |||
Millan Laboratories Ltd | unsuccessful | No Valid FMHACA Cert. | |||
Reyoung Pharma | unsuccessful | No Valid FMHACA Cert. | |||
Universa Coperationl | unsuccessful | No Valid FMHACA Cert. | |||
7 | Sulphamethoxazole + Trimethoprim (800mg+160mg) – Tablet | CANCELLED | |||